Cargando…

Impact of pharmacogenetics on aspirin resistance: a systematic review

Background  Pharmacogenetics promises better control of diseases such as cardiovascular disease (CVD). Acetylsalicylic acid, aspirin, prevents the formation of an activating agent of platelet aggregation and vasoconstriction, and it is used to prevent CVD. Nevertheless, patients may have treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Gustavo Figueiredo da, Lopes, Bruno Mattei, Moser, Vinicius, Ferreira, Leslie Ecker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014202/
https://www.ncbi.nlm.nih.gov/pubmed/36918009
http://dx.doi.org/10.1055/s-0042-1758445